A Case of Vogt-Koyanagi-Harada Disease-Like Uveitis Induced by Nivolumab and Ipilimumab Combination Therapy

Nivolumab and ipilimumab are widely used immune checkpoint inhibitors (ICPIs) for the treatment of metastatic melanoma. ICPIs cause an array of side effects called immune-related adverse events (IRAEs) due to activation of an immune response. ICPI-uveitis can cause irreversible vision loss if untrea...

Descripción completa

Detalles Bibliográficos
Autores principales: Minami, Keisuke, Egawa, Mariko, Kajita, Keisuke, Murao, Fumiko, Mitamura, Yoshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740278/
https://www.ncbi.nlm.nih.gov/pubmed/35082654
http://dx.doi.org/10.1159/000520416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740278/
https://www.ncbi.nlm.nih.gov/pubmed/35082654
http://dx.doi.org/10.1159/000520416

Ejemplares similares